FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2511-2513 December 8, 2005 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Wilder-Smith, A. PubMed Citation

To the Editor: Wilder-Smith and Schwartz (Sept. 1 issue)¹ mention that serotypes of dengue virus are distinguishable by the plaque-reduction neutralization test.² But they neglect to include this test in Table 2 of the article, which lists laboratory tests for the diagnosis of dengue. The concept that the plaque-reduction neutralization test is more specific than other serologic assays for the diagnosis of dengue and other flavivirus infections³ is confirmed by recent experience at the Wadsworth Center, operated by the New York State Department of Health. Since 1999, with the introduction of West Nile virus into the United States, the plaque-reduction . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.